ATH 20.0% 0.4¢ alterity therapeutics limited

big volumes traded on the nasdaq last night, page-28

  1. 5,878 Posts.
    lightbulb Created with Sketch. 148
    That's what I like about this stock. Just post the facts and it sounds like ramping.
    Look at Prana's co-founding scientists. Rudy Tanzi and Colin Masters are rated in the top handfull of Alzheimer's researchers worldwide, and the Journal of Alzheimer's disease illustrated that point when they started rating by citations.
    http://www.j-alz.com/cited
    OK being top of that list is not everything, considering Dennis Selkoe's baby was Bapi, but how pharmas could ignore similar opinions of two in the top 10 is puzzling, but hopefully that created an opportunity for a small investor like me.

    When you see the monumental blunders big pharma have made over the last few years, I tend to think not getting in early on PBT2 is another one.

    We will know soon enough:-)

    Please do your own DD. I am not a medical professional or investment advisor.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(20.0%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $640 160.0K

Buyers (Bids)

No. Vol. Price($)
60 69830906 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28778669 21
View Market Depth
Last trade - 10.21am 08/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.